Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 10
Submit an article Journal homepage
2,608
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction

Yongji Wanga Department of Health Statistics, School of Preventive Medicine, Air Force Military Medical University, Xi’an, Shaanxi, ChinaView further author information
,
Yangyang Qib Department of Statistics, Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, ChinaORCID Iconhttps://orcid.org/0000-0001-9139-9675View further author information
ORCID Icon,
Wenguo Xuc Department of Immunization Planning, Center for Disease Control and Prevention of Changzhou City, Changzhou, Jiangsu, ChinaView further author information
,
Yuansheng Hud Department of Clinical Research, Sinovac Biotech, Beijing, ChinaView further author information
,
Ling Wanga Department of Health Statistics, School of Preventive Medicine, Air Force Military Medical University, Xi’an, Shaanxi, ChinaView further author information
,
Yongpei Yue Department of Statistics, Peking University Clinical Research Institute, Peking University Health Science Center, Beijing, ChinaView further author information
,
Zhiwei Jiangb Department of Statistics, Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, ChinaView further author information
,
Jielai Xiaa Department of Health Statistics, School of Preventive Medicine, Air Force Military Medical University, Xi’an, Shaanxi, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1137-3198View further author information
ORCID Icon,
Gang Zengd Department of Clinical Research, Sinovac Biotech, Beijing, ChinaCorrespondence[email protected]
View further author information
&
Yalong Wangc Department of Immunization Planning, Center for Disease Control and Prevention of Changzhou City, Changzhou, Jiangsu, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 2559-2564 | Received 30 Sep 2019, Accepted 07 Jan 2020, Published online: 10 Feb 2020

References

  • Yu CK, Song YF, Qi YY, Li CJ, Jiang ZW, Li C, Zhang W, Wang L, Xia JL. Comparison of immunogenicity and persistence between inactivated hepatitis AvaccineHealive and Havrix among children: a 5-year follow-up study. Hum Vaccin Immunother. 2016;12(10):2595–602. PMID: 27385349. doi:10.1080/21645515.2016.1197450.
  • Rao S, Mao JS, Motlekar S, Zhuang FC, Kadhe G. A review of immunogenicity and tolerability of live attenuated hepatitis A vaccine in children. Hum Vaccin Immunother. 2016;12(12):3160–65. PMID: 27532370. doi:10.1080/21645515.2016.1216286.
  • Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, Shouval D, Bonanni P, Connor B, Cooksley G, et al. Hepatitis A booster vaccination: is there a need? Lancet. 2003;362(9389):1065–71. PMID: 14522539. doi:10.1016/S0140-6736(03)14418-2.
  • Monjori M, Shah N, Faridi M, Ghosh A, Sankaranarayanan VS, Aggarwal A, Chatterjee S, Bhattacharyya N, Kadhe G, Vishnoi G, et al. Long term follow-up study to evaluate immunogenicity and safety of a single dose of live attenuated hepatitis a vaccine in children. Hum Vaccin Immunother. 2015;11(5):1145–52. PMID: 26018443. doi:10.4161/21645515.2014.979646.
  • Lin YL, Chen GJ, Lee YL, Huang YC, Cheng A, Sun HY, Chang SY, Liu CE, Hung CC. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: a review. World J Gastroenterol. 2017;23(20):3589–606. doi:10.3748/wjg.v23.i20.3589.
  • Stuurman AL, Marano C, Bunge EM, De Moerlooze L, Shouval D. Impact of universal mass vaccination with monovalent inactivated hepatitisA vaccines - A systematic review. Hum Vaccin Immunother. 2017;13(3):724–36. PMID: 27786671. doi:10.1080/21645515.2016.1242539.
  • Advisory Committee on Immunization Practices, Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1–23. PMID: 16708058.
  • Cui F, Liang X, Wang F, Zheng H, Hutin YJ, Yang W. Development, production, and post marketing surveillance of hepatitis A vaccines in China. J Epidemiol. 2014;24(3):169–77. PMID: 24481843. doi:10.2188/jea.JE20130022.
  • Bhave S, Bavdekar A, Sapru A, Bawangade S, Pandit A. Immunogenicity of single dose live attenuated hepatitis a vaccine. Indian Pediatr. 2011;48(2):135–37. PMID: 21169655. doi:10.1007/s13312-011-0039-4.
  • Jiang WP, Chen JT, Wang X, Wang YL, Liu Y, Chen WY, Xu WG, Qiu YZ, Yin WD. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial. Vaccine. 2008;26(18):2297–301. PMID: 18395305. doi:10.1016/j.vaccine.2007.11.008.
  • Bu XY, Jin YP, Liu N, Deng GF, Xi Q, Yan SK. Assessment of microparticle enzyme immunoassay and electrochemiluminescence immunoassay for detection of HAV antibody. Labeled Immunoassays & Clin Med. 2010;17(1):34–36. CNKI:SUN:BJMY.0.2010-01-012.
  • Wiedermann G, Kundi M, Ambrosch F, Safary A, D’Hondt E, Delem A. Inactivated hepatitis A vaccine: long-term antibody persistence. Vaccine. 1997;15(6–7):612–15. PMID: 9178459. doi:10.1016/s0264-410x(96)00242-3.
  • Loutan L, Bovier P, Althaus B, Glück R. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. Lancet. 1994 5;343(8893):322–24. PMID: 7905144. doi:10.1016/s0140-6736(94)91162-2.
  • Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K. Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults. Vaccine. 2014;32(13):1507–13. PMID: 24508042. doi:10.1016/j.vaccine.2013.10.088.
  • DeSouza CM, Legedza AT, Sankoh AJ. An overview of practical approaches for handling missing data in clinical trials. J Biopharm Stat. 2009;19(6):1055–73. PMID: 20183464. doi:10.1080/10543400903242795.
  • Siddiqui O. MMRM versus MI in dealing with missing data-A comparison based on 25 NDA data sets. J Biopharm Stat. 2011;21(3):423–36. PMID: 21442517. doi:10.1080/10543401003777995.
  • Hammitt LL, Bulkow L, Hennessy TW, Zanis C, Snowball M, Williams JL, Bell BP, McMahon BJ. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis. 2008 15;198(12):1776–82. PMID: 18976095. doi:10.1086/593335.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.